Bringing Long-Term Continuous Glucose Monitoring to People with Diabetes

Senseonics is the creator of Eversense, the first and only long-term implantable continuous glucose monitoring (CGM) system for people with diabetes. The Eversense CGM system features a small sensor inserted under the skin that communicates with a smart transmitter worn over the sensor to provide glucose values, trends and alerts directly to a user's mobile device. This innovative system offers up to 180 days of continuous glucose monitoring from a single sensor insertion, surpassing other available CGM systems. Senseonics is dedicated to improving diabetes management by providing people with easy access to their glucose data. The company aims to enhance diabetes therapies by integrating glucose monitoring into a connected healthcare system.

With its breakthrough long-term implantable Eversense CGM, Senseonics is transforming diabetes management and giving users greater freedom and confidence.